Jae‐Cheol Jo

A prognostic index for natural killer cell lymphoma after non-anthracycline-based treatment: a multicentre, retrospective analysis

Seok Jin Kim, Dok Hyun Yoon, Arnaud Jaccard et al. · The Lancet Oncology · 2016 · 375 citations · Full text

Lymphoid Neoplasia, Oncology, Retrospective Analysis +7

Daratumumab plus bortezomib and dexamethasone <i>versus</i> bortezomib and dexamethasone in relapsed or refractory multiple myeloma: updated analysis of CASTOR

Andrew Spencer, Suzanne Lentzsch, Katja Weisel et al. · Haematologica · 2018 · 254 citations · Full text

Expression of programmed cell death 1 and programmed cell death ligand 1 in extranodal NK/T-cell lymphoma, nasal type

Jae‐Cheol Jo, Misung Kim, Yunsuk Choi et al. · Annals of Hematology · 2016 · 109 citations

Lymphoid Neoplasia, Extranodal Nk/t-cell Lymphoma, Immunology +6

Phase III trial of concurrent thoracic radiotherapy with either first- or third-cycle chemotherapy for limited-disease small-cell lung cancer

Jong‐Mu Sun, Yong Chan Ahn, Eun Kyung Choi et al. · Annals of Oncology · 2013 · 105 citations · Full text

Adaptive Radiotherapy, Concurrent Thoracic Radiotherapy, Radiation Therapy +9

Clinical Outcomes and Prognostic Factors of Up-Front Autologous Stem Cell Transplantation in Patients with Extranodal Natural Killer/T Cell Lymphoma

Ho‐Young Yhim, Jin Seok Kim, Yeung‐Chul Mun et al. · Biology of Blood and Marrow Transplantation · 2015 · 87 citations · Full text